340B Policy Landscape
|
|
- Marvin Kennedy
- 8 years ago
- Views:
Transcription
1 340B Policy Landscape Providence B Summit Presented by Steve Brennan, Director, Public Policy Providence Health & Services Sept. 28,
2 Today s topics Backdrop of debate over 340B program Legislative Activity in Washington, DC Providence engagement HRSA Omnibus Guidance Discussion 2
3 Government affairs is an integrated function serving all states Community engagement Government and public affairs Philanthropy Community benefit International health A standardized, consistent approach tailored to local needs 3
4 National, regional and local representation and engagement System core strategy Priorities and tactics Local action Creating healthier communities, together Annual advocacy strategic plan Advocacy, engagement, relationships Raising our Voice Legislation, policy and regulations relationships, engagement, memberships 4
5 FEDERAL ADVOCACY AND ENGAGEMENT The current landscape 5
6 Backdrop: Increasing Drug Prices Concern Growing Regarding High Drug Costs High cost of Hepatitis C drugs burden state Medicaid programs; legislatures in California, Oregon, other states look to respond Exponential price increases for certain drugs following acquisitions (5,000 % increase for Daraprim) Congress is considering drug reimportation, allowing CMS to negotiate with drug companies, barring pay for delay agreements, requiring rebates for Medicaid when generic prices increase, other responses to lower drug costs Presidential candidates Hillary Clinton, Bernie Sanders raising the issue on the campaign trail MedPAC studying options for Medicare program, including adding drug costs to ACO accountability 9/27/2015 6
7 340B Policy Debate Program established in 1992 in the Veterans Health Service Act to establish an upper limit on the prices of covered outpatient drugs sold to particular covered entities to improve access for underserved populations. The Affordable Care Act expanded the program types of entities eligible to participate in this program to include children s hospitals, critical access hospitals, free standing cancer hospitals, rural referral centers, and sole community hospitals. HRSA has estimated that this expansion enables up to 1,500 new facilities to become eligible to participate in the 340B program. Expansion of 340B prompted concerns, criticism over lack of regulatory oversight and moved beyond Congressional intent 7
8 340B Policy Debate, cont. Pharma, AIR 340B (includes oncology groups and others) spearheading advocacy campaign to tighten 340B program and reduce the number and types of facilities and providers eligible for 340B discounts for underserved populations. Pharma, AIR 340B (includes oncology groups and others) spearheading advocacy campaign to tighten 340B program and reduce the number and types of facilities and providers eligible for 340B discounts for underserved populations. Critics have garnered support from several key Members of Congress, most notably Senate Finance Committee Chairman Orrin Hatch (R-UT) Congressional pressure resulted in a GAO study that showed Medicare Part B drug spending is higher at 340B-eligible hospitals disputed by AHA, 340B Health, others House Energy & Commerce Health Subcommittee held a hearing in May to consider legislation to address criticism bill not introduced 8
9 Concerns Raised by 340B Critics: 9/27/2015 9
10 340B PROGRAM HRSA 340B Mega Guidance 10
11 Key Elements of the Proposed Guidance Category Proposed Changes Program Eligibility and Registration Use of 340B in connection with most services furnished outside the hospital would be prohibited; 340B only used for drugs that are ordered with a service that is billed as an outpatient not available upon discharge from an inpatient stay Limits physician-administered drugs to only orders written by a hospital provider affiliated providers not considered eligible. Drugs Eligible for Purchase Under 340B Excludes Medicaid drugs paid as part of a bundled rate from 340B eligibility; separately paid drugs remain eligible Hospitals subject to GPO exclusion have to ensure that any drugs are purchased on the correct accounts in order to comply with the prohibition. 11
12 Key Elements, Cont. Category Individuals Eligible to Receive 340B Drugs Proposed Changes Changes the definition of a Patient of a Covered Entity to include: Patient receives services at a facility or clinic site that is registered with the program and listed in the 340B database; Patient must receive services provided by a CE provider who is either employed by the CE or who is an independent contractor for the CE, such that the CE may bill for services on behalf of the provider; An individual would not be considered a patient of the CE whose only relationship is the dispensing or infusion of a drug An individual is considered a patient if his or her health care services is billed as an outpatient to the patient s insurance or 3 rd party payor; The individual patient s records are accessible to the CE and demonstrate that the CE is responsible for care. Demonstrates that the CE has a relationship for the services that result in the order or prescription and the CE retains responsibility for the care provided to the individual CE s must maintain records that demonstrate that all of the criteria above were met for every prescription or order. 12
13 Key Elements, Cont. Category Covered Entity Requirements; Prohibition of Duplicate Discounts Contract Pharmacy Arrangements Proposed Changes HRSA proposes to allow CEs to elect to carve in by having their Medicaid billing number, NPI or both listed on the 340B Medicaid Exclusion File. Also new guidance on Medicaid managed care, indicating that CEs can make different determinations regarding MCO patients than they do for FFS patients by either covered entity site and MCO. Where a contract pharmacy is listed on the 340B database, it will be presumed that the contract pharmacy will not dispense 340B drugs to Medicaid MCO or FFS patients, unless a written contract with the state is in place. Maintenance of Auditable Records: HRSA proposes a new standard of not less than five years for all 340B records, including those pertaining to child sites and contract pharmacies. A single CE can contract with a pharmacy only on its own behalf as an individual covered entity groups or networks of covered entities may not register or contract for pharmacy services on behalf of their individual covered entity members. HRSA warns that a CE contracting with a contract pharmacy should be aware of the federal anti-kickback statute and how such provisions could apply to arrangements with contract pharmacies. No further clarity is provided. 13
14 Next Steps Advocacy work going forward through the end of 2015 Legislative: Work with Sen. Wyden (OR), other key Members of Congress as they develop solutions to high drug costs As needed, engage with Congressional delegations to utilize their influence with HRSA on 340B guidance Coordinate with national associations, other organizations to prevent anti-340b legislation that may arise during the fall/winter Regulatory: Submit formal comments to HRSA on 340B guidance Communicate/educate internal leaders on final rule changes 14
15 Questions and discussion Together, we answer the call of every person we serve: Know me, care for me, ease my way 15
340B Drug Pricing Program: Recent Developments and Compliance Update
340B Drug Pricing Program: Recent Developments and Compliance Update Elizabeth S. Elson, Esq. Anil Shankar, Esq. November 19, 2015 Attorney Advertising Prior results do not guarantee a similar outcome
More informationFinally... maybe? The Long Awaited 340B Mega Guidance. Georgia Healthcare Financial Management Association. October 2015
Finally... maybe? The Long Awaited 340B Mega Guidance Georgia Healthcare Financial Management Association October 2015 Disclaimer This webinar assumes the participant is familiar with the basic operations
More information340B Drug Pricing Program: Overview and Recent Developments
340B Drug Pricing Program: Overview and Recent Developments November 12, 2015 Kirstin B. Ives Partner and Chair of Healthcare Litigation Group Williams Montgomery & John Ltd. 233 S. Wacker Drive, Suite
More informationLegal Alert. Long-Awaited 340B Program Guidance Now Available for Comments: What Stakeholders Need to Know. Authors
September 10, 2015 1 Legal Alert Authors Stephanie Trunk Partner stephanie.trunk@arentfox.com Erin E. Atkins Associate erin.atkins@arentfox.com Long-Awaited 340B Program Guidance Now Available for Comments:
More informationA fter much-anticipation, the Health Resources and
BNA s Health Care Policy Report Reproduced with permission from BNA s Health Care Policy Report, 23 HCPR 1420, 09/21/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
More information340B Drug Discount Program Overview and Emerging Issues
340B Drug Discount Program Overview and Emerging Issues I. APPLICABLE STATUTE AND OTHER LEGAL AUTHORITIES Section 340B of the Public Health Service Act (42 U.S.C. 256b) requires pharmaceutical manufacturers,
More information340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman
340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman Associates September 10, 2015 TODAY S AGENDA Background
More information340B Drug Pricing Program
340B Drug Pricing Program Chad E. Gay Director of Contract Compliance Agenda Discuss the 340B drug pricing program How the program is defined Who is eligible Enrollment Dates to be aware of Source Documentation
More informationFederal 340B Drug Pricing Program
2015 CliftonLarsonAllen LLP Federal 340B Drug Pricing Program March 6, 2015 Continuous learning in action Learning Objectives Explain the intent of the Federal 340B Drug Pricing Program List the eligibility
More informationXXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management
340B XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management 800.473.3516 www.wellpartner.com Table of Contents 340B Fundamentals for Health System Executive Management...1 What
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. 1 Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are we
More informationO n Aug. 28, the Department of Health and Human
BNA s Health Law Reporter Reproduced with permission from BNA s Health Law Reporter, 24 HLR 1202, 9/17/15. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com HRSA
More informationSpeakers. Recent Developments in 340B Drug Pricing Program Compliance and Enforcement. Elizabeth S. Elson, Esq. Anil Shankar, Esq.
1 Recent Developments in 340B Drug Pricing Program Compliance and Enforcement Elizabeth S. Elson, Esq. Anil Shankar, Esq. October 18, 2012 2 Speakers Elizabeth Elson Of Counsel Foley & Lardner LLP Los
More informationASHP Regulatory Alert
Proposed Guidance: 340B Drug Discount Program Introduction On Friday, August 28, 2015, the Health Resources and Services Administration (HRSA) published the long awaited proposed omnibus guidance for the
More informationCPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS
CPAs and ADVISORS experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS BRIAN M. BELL BRAD K. BROTHERTON DIRECTOR PARTNER MATERIALS COVERED TODAY 340B Program Evolution, Purpose & Benefits
More information7/16/2010. 14 th Annual 340B Coalition Conference July 19, 2010 Washington, DC. Safety Net Hospitals for Pharmaceutical Access
Safety Net Hospitals for Pharmaceutical Access The Story From Washington, D.C. Ted Slafsky Executive Director, SNHPA Editor in Chief, Drug Discount Monitor (202)552-58605860 ted.slafsky@snhpa.org 14 th
More information340B Drug Discount Program Identifying risks and internal audit focus areas
340B Drug Discount Program Identifying risks and internal audit focus areas Introduction The 340B Drug Discount Program is administered by the Health Resources and Services Administration (HRSA) Office
More information340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting
340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready Suzanne Herzog Founding Director Rx X Consulting What is 340B? 340B Overview A drug discount program that allows covered
More informationOctober 27, 2015. Attention: RIN 0906-AB08. RE: 340B Drug Pricing Program Omnibus Guidance. Dear Captain Pedley:
Captain Krista Pedley, Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, MD 20857 Attention: RIN 0906-AB08 RE: 340B Drug Pricing
More informationHot Topics in Medicaid
Hot Topics in Medicaid Chad Hope, Pharm.D. Pharmacy Program Manager DHSS/DHCS chad.hope@alaska.gov; 907-334-2654 ***These slides had to be submitted in December 2014 and may contain outdated information***
More information10/1/2013. Objectives. 340B Drug Pricing Program; Transitioning from Access to Integrity. 340B Stats, Arkansas. 340B Participating Entities, AR
Objectives Drug Pricing Program; Transitioning from Access to Integrity Arkansas Association of Health-system Pharmacists 47 th Annual Fall Seminar October 3 & 4, 2013 Chris Hatwig RPh, MS, FASHP President,
More informationToday s Agenda. Statement of Conflicts of Interest 7/9/2015
Geri Brennan Assistant Director, Health Care United States Government Accountability Office Statement of Conflicts of Interest Geri Brennan has no actual or potential conflict of interest in relation to
More informationNAMD WORKING PAPER SERIES. Medicaid and the 340B Program: Alignment and Modernization Opportunities
NAMD WORKING PAPER SERIES Medicaid and the 340B Program: Alignment and Modernization Opportunities May 2015 444 North Capitol Street, Suite 524 Washington, DC 20001 Phone: 202.403.8620 www.medicaiddirectors.org
More informationOverview of the 340B Drug Pricing Program
M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program 425 I Street, NW Suite 701 Washington, DC 20001
More informationGAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
GAO United States Government Accountability Office Report to Congressional Committees September 2011 DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs
More informationSUMMARY OF HRSA PROPOSED OMNIBUS GUIDANCE ON THE 340B DRUG DISCOUNT PROGRAM
L A W O F F I C E S HYMAN, PHELPS & MCNAMARA, P.C. 7 0 0 T H I R T E E N T H S T R E E T, N. W. S U I T E 1 2 0 0 W A S H I N G T O N, D. C. 2 0 0 0 5-5 9 2 9 ( 2 0 2 ) 7 3 7-5 6 0 0 F A C S I M I L E
More information340B Drug Pricing Program 340B Contract Pharmacy
340B Drug Pricing Program 340B Contract Pharmacy LTJG Enudio Mercado-Gonzalez, USPHS Program Management Officer U.S. Department of Health and Human Services Health Resources and Services Administration
More informationHHS Releases Long-Awaited 340B Proposed Guidance
AUGUST 31, 2015 HHS Releases Long-Awaited 340B Proposed Guidance David Ivill, Emily Cook and Joseph Parise On August 27, 2015, the U.S. Department of Health and Human Services (HHS) released the long-awaited
More information340B Drug Pricing Program. A Survey of the Program s Past, Present, and Future
340B Drug Pricing Program A Survey of the Program s Past, Present, and Future Presented by: Daniel Soldato Wyatt, Tarrant & Combs LLP dsoldato@wyattfirm.com (859) 288-7631 Disclaimer The views expressed
More information(RIN) 0906-AB08; 340-B
October, 2015 Ms. Krista Pedley Director, Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane, Mail Stop 08W05A Rockville, Maryland 20857 Re: Regulatory
More informationStructuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements
Presenting a live 90-minute webinar with interactive Q&A Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements THURSDAY, JUNE 4, 2015 1pm Eastern 12pm Central 11am
More informationThe 340B Drug Pricing Program. Ariel Winter and Daniel Zabinski November 6, 2014
The 340B Drug Pricing Program Ariel Winter and Daniel Zabinski November 6, 2014 Outline Background on 340B program Program has grown substantially 340B statute does not define key terms, allows many providers
More information340B Omnibus Guidance Would Significantly Narrow the Pool of Eligible Patients
White Paper August 31, 2015 340B Omnibus Guidance Would Significantly Narrow the Pool of Eligible Patients By Kristi V. Kung This client alert also was published as a bylined article on Law360 on September
More information340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY
CPAs & ADVISORS experience clarity // 340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY September 17, 2014 Michael Earls, CPA, Senior Manager September 17, 2014 OVERVIEW OF TODAY S PRESENTATION
More informationGROWTH OF THE 340B PROGRAM: PAST TRENDS, FUTURE PROJECTIONS
: PAST TRENDS, FUTURE PROJECTIONS Healthcare WHITE PAPER NOVEMBER 2014 Prepared By: Aaron Vandervelde avandervelde@thinkbrg.com 202.480.2661 Copyright 2014 by Berkeley Research Group, LLC. Except as may
More informationRE: 340B Drug Pricing Program Omnibus Guidance HRSA RIN 0906-AB08, (Vol. 80, No. 167, August 28, 2015)
October 26, 2015 Krista Pedley, PharmD, MS Captain, USPHS Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, Mail Stop 08W05A Rockville, MD 20857 Via Email:
More informationThe 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company
The 3 Keys to Success in Your 340B Program Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company Objectives Provide a description and overview of the 340B program Discuss
More informationKeep Your Savings: 340B Audits and Ensuring Compliance
Keep Your Savings: 340B Audits and Ensuring Compliance Disclosure This presentation reflects experience with the topics at hand and does not constitute legal advice, and does not reflect interpretation
More information340B Drug Discount Program 2013 March 15, 2013 1 Agenda 340B Program Overview Covered Entities Covered Drugs Covered Patients Why HRSA Audits How to Prepare for HRSA Audit Questions/Answers 2 340 DRUG
More informationMEDICARE PART B DRUGS. Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
United States Government Accountability Office Report to Congressional Requesters June 2015 MEDICARE PART B DRUGS Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
More information340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013
340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013 1 Agenda 340B Program Overview Why HRSA Audits? What will HRSA Audits Cover? Verification of Eligibility: Covered Entity,
More informationOctober 27, 2015. Krista Pedley, Director Office of Pharmacy Affairs Health Resources and Services Administration.
1015 15 th Street, N.W., Suite 950 Washington, DC 20005 Tel. 202.204.7508 Fax 202.204.7517 www.communityplans.net John Lovelace, Chairman Margaret A. Murray, Chief Executive Officer October 27, 2015 Krista
More information4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose
WHAT IS 340B? S C O T T M I L N E R P H AR M D, M B A DISCLOSURE No conflicts of interest to disclose 1 OBJECTIVES At the end of this presentation we should be able to: Describe the origin of the 340b
More informationDisclosure. Overview. Safety Net Hospitals for Pharmaceutical Access
340B: Issues and Opportunities in Pharmacy Automation Safety Net Hospitals for Pharmaceutical Access Executive Director, SNHPA Editor in Chief, Drug Discount Monitor American Society for Automation in
More information340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE. Presented by the American Bar Association Health Law Section and Center for Professional Development
340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE Presented by the American Bar Association Health Law Section and Center for Professional Development American Bar Association Center for Professional Development
More informationDSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing
DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing Presented by: Joe Metro, Partner Sal Rotella, Partner Agenda Disproportionate Share Hospital
More informationUNPRECEDENTED GROWTH, QUESTIONABLE POLICY: THE 340B DRUG PROGRAM
WORKING PAPER SERIES UNPRECEDENTED GROWTH, QUESTIONABLE POLICY: THE 340B DRUG PROGRAM BY STEPHEN T. PARENTE, PHD, MINNESOTA INSURANCE INDUSTRY CHAIR OF HEALTH FINANCE, DEPARTMENT OF FINANCE & MICHAEL RAMLET,
More informationThe 340B Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid
The Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid Barbara Straub Williams Powers Pyles Sutter & Verville PC American Health Lawyers Association 2014 Institute
More informationOIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015
OIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015 1. HRSA had been preparing a regulation to address the definition of a patient and hospital eligibility,
More informationSTATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS Daniel R. Levinson Inspector General September
More informationTEXAS VENDOR DRUG PROGRAM PHARMACY PROVIDER PROCEDURE MANUAL
1 OF 10 DOCUMENT HISTORY LOG STATUS REVISION EFFECTIVE DESCRIPTION Revision 1.1 Sep. 1, 2015 Baseline 1.0 Feb. 1, 2015 3.1 Eligible Entity 5 CAD Claim Submission o Instruction update and email address.
More information340B program presents opportunities and challenges
NOVEMBER 2009 healthcare financial management MEDICARE/MEDICAID Christopher L. Keough Stephanie A. Webster 340B program presents opportunities and challenges AT A GLANCE > The 340B program provides an
More information340B GROWTH AND THE IMPACT ON THE ONCOLOGY MARKETPLACE
340B GROWTH AND THE IMPACT ON THE ONCOLOGY MARKETPLACE Healthcare WHITE PAPER SEPTEMBER 2015 Prepared By: Aaron Vandervelde avanvervelde@thinkbrg.com 202.480.2661 Copyright 2015 by Berkeley Research Group,
More information340B Drug Pricing Program January 15, 2015
340B Drug Pricing Program January 15, 2015 340B Basics - Gary Merchant. MBA, BSPharm 340B Audit - Robert Theriault, MBA, BSPharm Declarations Neither Gary Merchant nor Robert Theriault have no actual or
More information340B Compliance Self-Assessment: Self-Audit Process Page 1 A Sample Self-Audit Process for Community Health Centers
340B Compliance Self-Assessment: Self-Audit Process Page 1 Purpose: The purpose of this tool is to provide a sample internal audit process to assist participating community health center (CHC) leaders
More informationThe Federal 340B Drug Discount Program: A Primer
The Federal 340B Drug Discount Program: A Primer Andrea G. Cohen Manatt, Phelps & Phillips, LLP Presentation to the National Medicaid Congress June 4, 2006 Preview 340B Program Overview What is it Who
More informationC. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs:
Title 23: Medicaid Part 200: General Provider Information Part 200 Chapter 4: Provider Enrollment Rule 4.10: 340B Providers A. The Division of Medicaid defines a 340B provider as a nonprofit healthcare
More informationCMS Pharmacy Update Part 1. Current Medicaid Issues
CMS Pharmacy Update Part 1 Eastern Medicaid Pharmacy Administrators Association (EMPAA) Conference November 9-12, 2008 The Greenbrier, White Sulfur Springs, West Virginia Joseph L. Fine, R.Ph, MPA Technical
More information340B PROGRAM. Scrutiny & Uncertainty Increase the Need for Compliance
340B PROGRAM Scrutiny & Uncertainty Increase the Need for Compliance Uncertainty will always be part of the taking charge process. Harold S. Geneen For many years, drug manufacturers and Covered Entities
More informationJuly 27, 2015. Dear Acting Administrator Slavitt:
Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-2390-P P.O. Box 8106 Baltimore, MD 21244-8016 Re: Proposed Rule for Medicaid and Children
More informationSTATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE
STATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE U.S. HOUSE ENERGY AND COMMERCE COMMITTEE SUBCOMMITEE ON HEALTH WASHINGTON, D.C. MARCH 5, 2015 Good
More informationThe 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render
The 340B Program: New Developments and New Opportunities for CAHs and Others Todd Nova Hall Render Wisconsin Office of Rural Health Hospital Finance Workshop August 30, 2011 What We Will Cover 2 340B Program
More informationHRSA Publishes 340B Drug Pricing Program Omnibus Guidance Notice: Significant Policy Ramifications Should Trigger Public Comment
Alert Life Sciences Health Industry If you have questions or would like additional information on the material covered in this Alert, please contact one of the attorneys listed below: Joseph W. Metro Partner,
More information340B Compliance: I sure wish I d known that!
340B Compliance: I sure wish I d known that! Aaron K. Lott Pharm. D. Executive Director of Pharmacy Services June 2015 Disclosures The presenter has no significant financial or commercial interests to
More informationThe 340B Drug Pricing Program: The Basics
The 340B Drug Pricing Program: The Basics Paul Shank, MBA Health & Human Services Consultant, Health Resources and Services Administration Healthcare Systems Bureau, Office of Pharmacy Affairs July 14,
More informationThe Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare
The Pharmacy 340B Program- Compliance & Internal Audit Strategies Matthew D. Vogelien Huron Healthcare for Covered Entities 340B Drug Discount Program (340B Program) Discussion Outline Topics for Discussion:
More information340B DISCOUNT DRUG PROGRAM OVERVIEW
340B DISCOUNT DRUG PROGRAM OVERVIEW March 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which
More informationHRSA Issues 340B Program Omnibus Guidance
3 September 2015 Practice Groups: Healthcare FDA HRSA Issues 340B Program Omnibus Guidance By Gina L. Bertolini, Richard P. Church, Leah D'Aurora Richardson On August 28, 2015, the Health Resources and
More informationMaximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar
Maximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar January 20, 2010 The Webinar Will Begin Momentarily National Association of Public Hospitals and Health
More informationTHE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program
THE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program WINTER 2013 A publication of the following organizations: the Biotechnology Industry Organization (BIO), the Community Oncology
More information340B University Page 1 340B Manager and Coordinator Job Description Template
340B University Page 1 Purpose: The purpose of this tool is to provide a list of activities commonly assigned to the role of 340B Manager or Coordinator. This list is not exhaustive, rather a compilation
More informationMEDICARE. Increasing Hospital- Physician Consolidation Highlights Need for Payment Reform
United States Government Accountability Office Report to Congressional Requesters December 2015 MEDICARE Increasing Hospital- Physician Consolidation Highlights Need for Payment Reform GAO-16-189 December
More informationOctober 9, 2015. RIN 0906-AB08 340B Drug Pricing Program Omnibus Guidance. Dear Director Pedley:
October 9, 2015 Krista Pedley Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, Maryland 20857 Re: RIN 0906-AB08 340B Drug
More informationPRINCIPAL DEPUTY ADMINISTRATOR, DEPUTY ADMINISTRATOR FOR INNOVATION AND QUALITY, AND CHIEF MEDICAL OFFICER, CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF PATRICK CONWAY, MD, MSc ACTING PRINCIPAL DEPUTY ADMINISTRATOR, DEPUTY ADMINISTRATOR FOR INNOVATION AND QUALITY, AND CHIEF MEDICAL OFFICER, CENTERS FOR MEDICARE & MEDICAID SERVICES ON EXAMINING
More informationVia Electronic Submission at http://www.regulations.gov. October 27, 2015
Via Electronic Submission at http://www.regulations.gov October 27, 2015 Krista Pedley, PharmD, MS Captain, United States Public Health Service Director, Office of Pharmacy Affairs Health Resources and
More information340B Program New Developments and Increasing Scrutiny
340B Program New Developments and Increasing Scrutiny Todd Nova Hall Render tnova@hallrender.com Wisconsin Office of Rural Health Hospital Finance Workshop August 24, 2012 What We Will Cover 2 340B Program
More informationSec. 340B PUBLIC HEALTH SERVICE ACT
Sec. 340B PUBLIC HEALTH SERVICE ACT LIMITATION ON PRICES OF DRUGS PURCHASED BY COVERED ENTITIES (a) REQUIREMENTS FOR AGREEMENT WITH SECRETARY. (1) IN GENERAL. The Secretary shall enter into an agreement
More informationTHE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program
THE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program WINTER 2013 A publication of the following organizations: the Biotechnology Industry Organization (BIO), the Community Oncology
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. Senate Special Committee on Aging. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Special Committee on Aging Hearing on: 10 Years Later: A Look at the Medicare Prescription Drug Program 2:30 p.m. 366 Dirksen
More informationMEDICAID PAYMENT. Comparisons of Selected Services under Fee-for- Service, Managed Care, and Private Insurance
United States Government Accountability Office Report to Congressional Committees July 2014 MEDICAID PAYMENT Comparisons of Selected Services under Fee-for- Service, Managed Care, and Private Insurance
More informationEnsuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability
Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Fern Paul-Aviles, PharmD, MS, BCPS Director, 340B and Ambulatory Regulatory Program Compliance Carolinas Healthcare
More informationTable of Contents. State Plan Amendment (SPA) #: 09-021B This file contains the following documents in the order listed:
Table of Contents (Cover Page) for one PDF to post on Medicaid.gov Sample Template is below this line. Do not print the wording above this line. Table of Contents State/Territory Name: California State
More informationPayor Perspectives on Provider Realignment and ACOs
Payor Perspectives on Provider Realignment and ACOs Joel L. Michaels March 15, 2011 Overview Issues to be addressed Medicare Shared Savings Program overview ACO organization options Health care reform
More informationUnfulfilled Expectations: An analysis of charity care provided by 340B hospitals
Unfulfilled Expectations: An analysis of charity care provided by 340B hospitals A publication of the Alliance for Integrity and Reform of 340B (AIR 340B). Avalere Health performed supporting research
More informationThe American Tax Relief Act of 2012 Summary of Health Care Related Provisions January 2013
of 2012 Summary of Health Care Related Provisions On January 3, President Obama signed the American Tax Relief Act of 2012 (ATRA) to partially avert the so-called fiscal cliff, which would have resulted
More informationVAHO FALL MEETING. Oncology Policy, Pricing, and Payment Reform Issues from DC Down the Road to Richmond. Ted Okon Richmond, Virginia 10/2/15
VAHO FALL MEETING Oncology Policy, Pricing, and Payment Reform Issues from DC Down the Road to Richmond Ted Okon Richmond, Virginia 10/2/15 1 One Slide Summary Cancer care landscape is consolidating Movement
More information2015-340B & Prime Vendor Program Update
2015-340B & Prime Vendor Program Update Christopher A. Hatwig, R.Ph., MS, FASHP President, Apexus 340B Sales by Entity Types Percentage of Total Apexus Participant Sales 90.00% 80.00% 70.00% 60.00% 50.00%
More informationStatement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010
Statement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010 Laurel Todd Director, Reimbursement and Health Policy Biotechnology
More informationSubject: Electronic Health Records: Number and Characteristics of Providers Awarded Medicare Incentive Payments for 2011
United States Government Accountability Office Washington, DC 20548 July 26, 2012 Congressional Committees Subject: Electronic Health Records: Number and Characteristics of Providers Awarded Medicare Incentive
More informationStark and Anti-kickback Regulations: Proposed Changes for E-prescribing and Electronic Health Records
Regulatory Advisory This Regulatory Advisory, a special service to America s hospitals, contains guidance about physician self-referral and anti-kickback regulations. Stark and Anti-kickback Regulations:
More informationPRICE REPORTING COMPLIANCE: BEST PRACTICES IN REPORTING MEDICAID DRUG REBATE PROGRAM AND PART B ASP DATA. November 16, 2004
PRICE REPORTING COMPLIANCE: BEST PRACTICES IN REPORTING MEDICAID DRUG REBATE PROGRAM AND PART B ASP DATA November 16, 2004 Andrew Ruskin Vinson & Elkins LLP Washington, DC Medicaid Drug Rebate Program
More informationIs your organization 340B equipped? Understanding Contract Pharmacy arrangements
Is your organization 340B equipped? Understanding Contract Pharmacy arrangements In today s era of healthcare reform that emphasizes enhanced accessibility and cost reductions, the 340B program remains
More informationRE: File Code CMS 2345 P: Medicaid Program; Covered Outpatient Drugs
April 2, 2012 Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS 2345 P Mail Stop C4-26-05 7500 Security Boulevard Baltimore, MD 21244 1850 RE: File Code CMS
More informationJune 18, 2015. 219 Dirksen Senate Building 221 Dirksen Senate Building Washington, D.C. 20510 Washington, D.C. 20510
June 18, 2015 The Honorable Orrin Hatch The Honorable Ron Wyden Chairman Ranking Member Senate Finance Committee Senate Finance Committee 219 Dirksen Senate Building 221 Dirksen Senate Building Washington,
More informationOctober 26, 2015. Submitted electronically via http://www.regulations.gov. Re: RIN 0906-AB08; 340B Drug Pricing Program Omnibus Guidance
20555 Victor Parkway Livonia, MI 48152 tel 734-343-1000 trinity-health.org October 26, 2015 Captain Krista Pedley, PharmD, MS Director Office of Pharmacy Affairs Health Resources and Services Administration
More informationThe 340B Program: Today and Beyond
FL Regional Education Session - Tampa The 340B Program: Today and Beyond May 19, 2015 2:15-3:15 PM ET 2015 Safety Net Hospitals for Pharmaceutical Access 1 Disclaimer This presentation is not to be construed
More informationHRSA Issues Proposed Omnibus 340B Guidance
HRSA Issues Proposed Omnibus 340B Guidance September 2015 1 HRSA Issues Proposed Omnibus 340B Guidance John Gould, Jeffrey L. Handwerker, Rosemary Maxwell, Matthew T. Fornataro, Kristin M. Hicks, Rahul
More informationImplementing a System-wide 340B Program
Implementing a System-wide 340B Program An Overview Steve Pitzer System Executive, Supply Chain Management CHRISTUS Health Sam Colletti, RPh Director of Enterprise Accounts- CHRISTUS Health Broadlane Objectives
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration RIN 0906-AB08 340B Drug Pricing Program Omnibus Guidance
Page 1 THOT Members AUSTIN Central Health Seton Healthcare Family CORPUS CHRISTI CHRISTUS Spohn Health System Nueces County Hospital District DALLAS Children s Health System of Texas Parkland Health &
More information